Contamination troubles strike GSK


Pharma giant GlaxoSmithKline (GSK) has been warned by the US Food and Drug Administration (FDA) to address manufacturing problems at the SmithKline Beecham chemical plant in Cork, Ireland, after FDA inspectors found evidence of contamination.

In a warning letter to the company’s chief executive, FDA officials raised concerns over contamination of active pharmaceutical ingredients with solvents and intermediates from a waste tank. The letter criticised GSK’s initial response to the issues, saying that some product batches were shipped despite others being held back, and that the equipment checks were inadequate to rule out further contamination. This is not the first time the company has been in trouble over manufacturing practices. In 2010 they agreed to pay $750 million (£452 million) to settle charges relating to the manufacture of adulterated drugs at the now closed plant at Cidra, Puerto Rico.

Meanwhile, GSK has recalled all supplies of weight loss drug Alli from retailers in the US in response to widespread reports of product tampering. Customers from seven states have reported finding fake pills that are the wrong colour, or bottles with broken seals inside the outer packaging of Alli products bought from drug stores. GSK has recalled all supplies sold in US stores while it investigates, and has urged customers to come forward if they suspect that their product has been interfered with.


Related Content

Court convicts ex-Aptuit researcher over drug data

21 March 2013 Business

news image

Altered liquid chromatography results at Scottish site lead to first successful good lab practice prosecution

Forensic chemist imprisoned for falsifying tests

27 November 2013 News and Analysis

news image

US crime lab analyst sentenced to three to five years for tampering with narcotics evidence, obstructing justice

Most Read

Better batteries with pure lithium anodes

28 July 2014 Research

news image

Protective carbon nanosphere coating overcomes lithium problems, pointing the way to improved capacity

Takeover battle pushes Allergan to cut R&D jobs

28 July 2014 Business

news image

Besieged by serially acquisitive Valeant, the Botox maker will lay off 1500 staff to propel earnings growth

Most Commented

Bubble wrap could send lab costs packing

23 July 2014 Research

news image

Potential bubbles up across wide range of uses as storage and test vessels, especially for poor countries

Relativity behind mercury's liquidity

21 June 2013 Research

news image

First evidence that relativistic effects are indeed responsible for mercury's low melting point